Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

292

HTML

1623

Figures (1-4)

178

Tables (1-1)

175

Sum=2268

Jan 7, 2010 (publication date) through Jul 16, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jan 7, 2010; 16(1): 112-118
Published online Jan 7, 2010. doi: 10.3748/wjg.v16.i1.112

Full Size Figure Download Figure

Figure 3 FAP-1 siRNA increasing the inhibitory effect of oxaliplatin on proliferation of SW480 cells.

Citation: Xiao ZY, Wu W, Eagleton N, Chen HQ, Shao J, Teng H, Liu TH, Jiang ZM, Yao HR. Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin. World J Gastroenterol 2010; 16(1): 112-118
URL: https://www.wjgnet.com/1007-9327/full/v16/i1/112.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i1.112